Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Endometrial Neoplasms × Tamoxifen × Clear all

Status

Sponsor Class

Study Type

Interventional 4 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 18 Obesity 2 Neoplasm Metastasis 2 Vitamin D Deficiency 1 Sleep Wake Disorders 1 Recurrence 1 Precancerous Conditions 1 Nutrition Disorders 1 Neoplasms 1 Muscle Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Hot Flashes 1 Hormone-receptor-positive Breast Cancer 1 Endometrial Neoplasms 1 Depression 1 Chronic Pain 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Cancer Organoids 1 Arthralgia 1

Interventions

Surveys and Questionnaires 16 Blood Specimen Collection 7 Hysteroscopy 5 Surgical Procedures, Operative 4 Observation 4 Interviews as Topic 4 Hysterectomy 4 Magnetic Resonance Spectroscopy 3 Ultrasonography 2 Specimen Handling 2 Sentinel Lymph Node Biopsy 2 Reverse Transcriptase Polymerase Chain Reaction 2 Psychiatric Rehabilitation 2 Laparoscopy 2 Immunohistochemistry 2 High-Energy Shock Waves 2 Drug Therapy 2 Data Collection 2 Biopsy 2 Base Sequence 2 trastuzumab deruxtecan 1 semaglutide 1 sarcolipin 1 rubitecan 1 olaparib 1 dostarlimab 1 dexamethasone 21-phosphate 1 apixaban 1 X-Rays 1 Vaginal Smears 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03621904 2023-01-18

PROMOTE

Radboud University Medical Center

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡